Kai Hou

1.8k total citations
65 papers, 1.4k citations indexed

About

Kai Hou is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kai Hou has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kai Hou's work include Silk-based biomaterials and applications (5 papers), MicroRNA in disease regulation (4 papers) and Renal Diseases and Glomerulopathies (4 papers). Kai Hou is often cited by papers focused on Silk-based biomaterials and applications (5 papers), MicroRNA in disease regulation (4 papers) and Renal Diseases and Glomerulopathies (4 papers). Kai Hou collaborates with scholars based in China, United States and India. Kai Hou's co-authors include Yunman Li, Fengyang Li, Weirong Fang, Dan Xu, Xiangmei Chen, Shijie Chen, Xue Gou, Yiping Wu, Dan Xu and Guangyan Cai and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.

In The Last Decade

Kai Hou

62 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Hou China 23 651 239 188 169 145 65 1.4k
Chun Guo China 26 974 1.5× 203 0.8× 147 0.8× 105 0.6× 148 1.0× 56 1.8k
Pingzhen Yang China 21 585 0.9× 124 0.5× 265 1.4× 136 0.8× 196 1.4× 55 1.3k
Min Zeng China 23 567 0.9× 165 0.7× 130 0.7× 58 0.3× 79 0.5× 62 1.5k
Kyoungmin Park United States 25 730 1.1× 184 0.8× 209 1.1× 119 0.7× 212 1.5× 48 1.7k
Amaneh Mohammadi Roushandeh Iran 26 918 1.4× 350 1.5× 192 1.0× 227 1.3× 276 1.9× 102 2.0k
You Li China 23 1.1k 1.7× 729 3.1× 200 1.1× 144 0.9× 171 1.2× 79 2.4k
Wei Liang China 24 664 1.0× 136 0.6× 158 0.8× 283 1.7× 148 1.0× 51 1.5k
Xiaoming Ding China 20 551 0.8× 267 1.1× 124 0.7× 154 0.9× 414 2.9× 121 1.6k

Countries citing papers authored by Kai Hou

Since Specialization
Citations

This map shows the geographic impact of Kai Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Hou more than expected).

Fields of papers citing papers by Kai Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Hou. The network helps show where Kai Hou may publish in the future.

Co-authorship network of co-authors of Kai Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Hou. A scholar is included among the top collaborators of Kai Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Hou. Kai Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Kai, Ke Pan, Dan Xu, Yunman Li, & Hailong Cao. (2025). Indobufen alleviates apoptosis by the PI3K/Akt/eNOS pathway in myocardial ischemia‒reperfusion (I/R) injury. Scientific Reports. 15(1). 34400–34400.
2.
Hou, Kai, Lin Liu, Zhihui Fang, et al.. (2024). The role of ferroptosis in cardio-oncology. Archives of Toxicology. 98(3). 709–734. 6 indexed citations
3.
Fu, Xinghe, et al.. (2024). Fault Diagnosis of an Excitation System Using a Fuzzy Neural Network Optimized by a Novel Adaptive Grey Wolf Optimizer. Processes. 12(9). 2032–2032. 3 indexed citations
5.
Ma, Yu, Qi Zhang, Lu Cao, et al.. (2022). Effect of PCSK9 Inhibitor on Contrast-Induced Acute Kidney Injury in Patients with Acute Myocardial Infarction Undergoing Intervention Therapy. Cardiology Research and Practice. 2022. 1–7. 5 indexed citations
6.
Hou, Kai, et al.. (2022). Screening of potential microbial markers for lung cancer using metagenomic sequencing. Cancer Medicine. 12(6). 7127–7139. 7 indexed citations
7.
Wang, Yichen, Qi Zhang, Yufang Tan, et al.. (2022). Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma. Frontiers in Oncology. 11. 785887–785887. 27 indexed citations
8.
Wang, Zhiqian, et al.. (2021). The susceptibility of SERPINE1 rs1799889 SNP in diabetic vascular complications: a meta-analysis of fifty-one case-control studies. BMC Endocrine Disorders. 21(1). 195–195. 4 indexed citations
9.
Hou, Kai, et al.. (2020). Effects of miR-124-3p regulation of the p38MAPK signaling pathway via MEKK3 on apoptosis and proliferation of macrophages in mice with coronary atherosclerosis. Advances in Clinical and Experimental Medicine. 29(7). 803–812. 16 indexed citations
10.
Wang, Yuancheng, Sheng Xu, Riyuan Wang, et al.. (2019). Genetic fabrication of functional silk mats with improved cell proliferation activity for medical applications. Biomaterials Science. 7(11). 4536–4546. 14 indexed citations
11.
Wang, Feng, Kai Hou, Wenjing Chen, et al.. (2019). Transgenic PDGF-BB/sericin hydrogel supports for cell proliferation and osteogenic differentiation. Biomaterials Science. 8(2). 657–672. 31 indexed citations
12.
Fei, Yuxiang, Dan Xu, Kai Hou, et al.. (2019). Pharmacokinetics and pharmacodynamics analysis of XQ-1H and its combination therapy with clopidogrel on cerebral ischemic reperfusion injury in rats. Journal of Pharmaceutical and Biomedical Analysis. 179. 112975–112975. 1 indexed citations
14.
Chen, Wenjing, Feng Wang, Tian Chi, et al.. (2018). Transgenic Silkworm-Based Silk Gland Bioreactor for Large Scale Production of Bioactive Human Platelet-Derived Growth Factor (PDGF-BB) in Silk Cocoons. International Journal of Molecular Sciences. 19(9). 2533–2533. 28 indexed citations
15.
Wang, Yuancheng, Feng Wang, Sheng Xu, et al.. (2018). Genetically engineered bi-functional silk material with improved cell proliferation and anti-inflammatory activity for medical application. Acta Biomaterialia. 86. 148–157. 33 indexed citations
16.
Wang, Zuowei, et al.. (2017). A controlled, multi-center, randomized study of efficacy and safety of troxerutin and cerebroprotein hydrolysate injection for traumatic brain injury. Zhonghua shenjing waike zazhi. 33(7). 669–672. 1 indexed citations
17.
Liang, Shuang, Guangyan Cai, Zhi-Yu Duan, et al.. (2015). Urinary Sediment miRNAs Reflect Tubulointerstitial Damage and Therapeutic Response in IgA Nephropathy. Hong Kong Journal of Nephrology. 17(2). S33–S33. 3 indexed citations
18.
Wu, Lingling, Zhe Feng, Shaoyuan Cui, et al.. (2013). Rapamycin Upregulates Autophagy by Inhibiting the mTOR-ULK1 Pathway, Resulting in Reduced Podocyte Injury. PLoS ONE. 8(5). e63799–e63799. 99 indexed citations
19.
Wang, Liyuan, Quan Hong, Yang Lv, et al.. (2012). Autophagy can repair endoplasmic reticulum stress damage of the passive Heymann nephritis model as revealed by proteomics analysis. Journal of Proteomics. 75(13). 3866–3876. 37 indexed citations
20.
Chen, Qiang, Kai Hou, Zhenxing Zhang, Yuquan Zhu, & Tieying Song. (2006). Acute occlusion of the left subclavian artery with artery dissection. Chinese Medical Journal. 119(3). 255–258. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026